Warum steigt der Aktienkurs von QUEST DIAGNOSTICS INCORPORATED?
Bullen sagen
Utilization-driven revenue growth
Strong utilization across physician, hospital, and other channels supports steady revenue growth as volumes increase across customer groups.
Consumer testing expansion
Direct-to-consumer testing and high-value test panels are driving incremental revenue and raising revenue per requisition.
Platform and diagnostic innovation
Progress on the Haystack platform and planned electronic medical record integration, together with expansion of advanced diagnostics, could lift test volumes by simplifying ordering and expanding coverage opportunities.
Reimbursement pressure
Reimbursement reductions under government payment programs are creating pressure on revenue and margins, presenting a notable headwind to profitability.
Margin and partner disruptions
Operating margins face near-term pressure from project-related expenses and partner disruptions, which may slow the conversion of top-line gains into earnings.
Insurance losses and bad debt risk
Larger-than-expected losses of insurance coverage for some patients and rising bad debt expense could reduce lab volumes and increase costs related to unpaid bills.
